Chenodal (Manchester Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Chenodal drug offered from Manchester Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Manchester Pharmaceuticals Inc.
NON-PROPRIETARY NAME: Chenodiol
SUBSTANCE NAME: CHENODIOL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-10-01
END MARKETING DATE: 0000-00-00


Chenodal HUMAN PRESCRIPTION DRUG Details:

Item DescriptionChenodal from Manchester Pharmaceuticals Inc.
LABELER NAME: Manchester Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2009-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 45043-876_d6369783-3cd7-4d99-8ddd-07102a5512f9
PRODUCT NDC: 45043-876
APPLICATION NUMBER: ANDA091019

Other CHENODIOL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Manchester Pharmaceuticals Inc.Chenodal
Nexgen Pharma, Inc.Chenodiol
Retrophin, Inc.Chenodal